EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Survival and Renal Recovery in Newly Diagnosed Multiple Myeloma Patients Presenting With Dialysis‐Requiring Severe Renal Impairment

Rintu Sharma iD, Eshetu G Atenafu, Esther Masih-Khan, Harjot Vohra, Sita Bhella, Christine Chen iD, Vishal Kukreti, Guido Lancman, Anca Prica, A Keith Stewart, Rodger Tiedemann, Suzanne Trudel und 2 weitere

European Journal of Haematology · 2026-05 · 116 (5) · 577-584

DOI: 10.1111/ejh.70116 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Haematology, online erschienen am 14.01.2026. Verfasst von Rintu Sharma und 13 weiteren Autor:innen. Beteiligte Einrichtung: Princess Margaret Cancer Center, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Multiple Myeloma, Renal Dialysis, Renal Insufficiency. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Severe renal insufficiency requiring dialysis in newly diagnosed multiple myeloma (NDMM) patients has been independently associated with poor survival outcomes. However, there is a paucity of data on factors predicting renal recovery and survival outcomes of these patients.

Methods

We retrospectively analyzed outcomes in NDMM patients presenting with severe dialysis‐requiring RI from 01/2010 to 12/2022.

Results

Seventy patients were identified; all receiving novel agent‐based induction (bortezomib‐based 96%; lenalidomide‐based 3%)—73% ( n = 51) underwent ASCT. Thirty‐three (48%) patients became dialysis independent; early achievement of VGPR in < 4.4 months from treatment initiation was identified as the only factor predicting renal recovery and dialysis withdrawal on univariate analysis (Hazard ratio [HR] of 4.172; p‐ value = 0.0014). At median follow‐up of 39 months, the median overall survival (OS) of dialysis‐requiring NDMM patients was 98.3 months with 2‐ and 5‐year OS rates of 84% and 67%, respectively; 2‐ and 5‐year progression‐free survival (PFS) rates were 66.9% and 43.7%, respectively. On multivariable analysis, low LDH at diagnosis (HR: 1.003, p = 0.0092), undergoing ASCT (HR: 0.213; p ‐value = 0.0016), and dialysis independence (HR: 0.311; p ‐value = 0.0112) independently predicted improved OS.

Conclusions

Early VGPR and hemodialysis independence translated to improved survival, providing a benchmark for future comparison as anti‐CD38 monoclonal antibodies enter first line therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaRenal DialysisRenal InsufficiencyHumansFemaleMaleAgedMiddle AgedRetrospective StudiesAntineoplastic Combined Chemotherapy ProtocolsPrognosis

Stichwörter der Autor:innen

dialysisnewly diagnosed multiple myelomaoutcomesrenal impairmentrenal recoverysurvival

Autor:innen und Institutionen

  • Princess Margaret Cancer Center, Toronto, ON, Canada.
  • Biostatistics, University Health Network, Toronto, ON, Canada.
  • University of Auckland, Auckland, New Zealand.

ORCID-Profile: Rintu Sharma, Christine Chen

Zitieren

APA

Sharma, R., Atenafu, E. G., Masih-Khan, E., Vohra, H., Bhella, S., Chen, C., Kukreti, V., Lancman, G., Prica, A., Stewart, A. K., Tiedemann, R., Trudel, S., Yang, C., & Reece, D. (2026). Survival and Renal Recovery in Newly Diagnosed Multiple Myeloma Patients Presenting With Dialysis‐Requiring Severe Renal Impairment. European Journal of Haematology, 116(5), 577-584. https://doi.org/10.1111/ejh.70116

Vancouver

Sharma R, Atenafu EG, Masih-Khan E, Vohra H, Bhella S, Chen C, et al. Survival and Renal Recovery in Newly Diagnosed Multiple Myeloma Patients Presenting With Dialysis‐Requiring Severe Renal Impairment. European Journal of Haematology. 2026;116(5):577-584. doi:10.1111/ejh.70116

BibTeX
@article{Sharma2026,
  author = {Sharma, Rintu and Atenafu, Eshetu G and Masih-Khan, Esther and Vohra, Harjot and Bhella, Sita and Chen, Christine and Kukreti, Vishal and Lancman, Guido and Prica, Anca and Stewart, A Keith and Tiedemann, Rodger and Trudel, Suzanne and Yang, Chloe and Reece, Donna},
  title = {Survival and Renal Recovery in Newly Diagnosed Multiple Myeloma Patients Presenting With Dialysis‐Requiring Severe Renal Impairment},
  journal = {European Journal of Haematology},
  year = {2026},
  volume = {116},
  number = {5},
  pages = {577--584},
  doi = {10.1111/ejh.70116}
}
Kostenlos starten →